KOWA COMPANY, LTD. (E02819) Stock Price

Kowa is a diversified company with pharmaceutical operations at its core, combined with trading and manufacturing functions. The company's main business is the development, manufacturing, and sales of prescription and over-the-counter medicines. It is widely recognized by consumers for nutritional drinks such as Kewpie Kowa Gold and cold medicines. The company also operates trading functions in textiles, chemicals, and building materials, as well as optical equipment and environmental-related businesses.

The company's revenue structure comprises seven business segments, with pharmaceuticals playing a central role. In the pharmaceutical business, it sells prescription medicines to hospitals and clinics, and over-the-counter medicines to pharmacies and drugstores, establishing a stable revenue base. In industrial-related operations, it sells solar-related materials and chemicals to domestic and overseas companies. In hospitality operations, it also manages properties such as Nagoya Kanko Hotel.

The company's operations are divided into seven fields: consumer-related, industrial-related, pharmaceuticals, environment and energy efficiency, real estate, hospitality, and other businesses. In pharmaceuticals, it offers a wide range of products from prescription medicines such as hyperlipidemia and diabetes treatments to over-the-counter medicines including gastrointestinal and cold remedies. In environment and energy efficiency operations, it handles industrial monitoring systems, optical equipment, and energy-efficient buildings, operating globally through 117 subsidiaries and affiliated companies.

Kowa is a company with over 130 years of history that has attracted investor attention as it pursues diversified business operations centered on the themes of "health and environment." The company has built a unique business model combining pharmaceutical operations with trading and manufacturing functions, and has responded nimbly to changing times. Currently, it operates across six major business segments—pharmaceuticals, industrial-related, lifestyle-related, environment and energy efficiency, real estate, and hospitality—and is advancing a growth strategy that leverages synergies across each field.

In pharmaceuticals, the company has established vertical integration from research and development through manufacturing, sales, and logistics, with focus areas in lifestyle disease treatment such as type 2 diabetes and hyperlipidemia, and sensory organ treatment such as glaucoma therapy. While accelerating overseas expansion of prescription pharmaceuticals, Kowa is also investing in medical devices such as intraocular lenses for cataract treatment, differentiating itself through "hybrid-type" business operations. The company also handles infection control products such as antigen test kits, building a broad product portfolio related to health and medical care.

In industrial-related operations, the company is actively pursuing new business investments with emphasis on contributing to a decarbonized society. Kowa operates diverse businesses ranging from lithium battery material trading to solar power generation modules and LNG carrier chartering services. Particularly noteworthy is the green ammonia business launched in partnership with an Indian partner. This project, which handles manufacturing, logistics, and sales in an integrated manner, is expected as a strategic investment targeting growth opportunities in the next-generation energy sector.

In environment and energy efficiency operations, the company focuses on providing proprietary solutions utilizing optical and AI technologies. Kowa differentiates itself in industrial optical equipment business through its proprietary vision units, with products leveraging environmental durability enabling deployment in harsh environments. Additionally, the company comprehensively provides energy creation and efficiency solutions ranging from solar equipment installation to PPA business, building an operational foundation that supports corporate environmental management. Through these technology innovation initiatives, the company aims for sustainable growth with a perspective extending 100 to 200 years into the future.